Kiran Mazumdar-Shaw has named Claire Mazumdar as her successor to lead Biocon, signalling a key leadership transition at the biotech firm. Claire, 37, currently serves as CEO of Bicara Therapeutics and brings experience in business development and corporate strategy, along with board roles at Relay Therapeutics and Noora Health.
